The Platelet Extinction Coefficient Measured by Aggregometry Is Dependent on Platelet Composition rather than Size: Implications for Studies of Platelet Heterogeneity and Abnormalities

Summary

Extinction (E) or light transmission measurements of platelet suspensions have been widely used to evaluate platelet structure and aggregation for platelet populations of varying mean platelet size (V). However, useful comparisons of platelet suspensions from donors having abnormally-sized platelets with those from healthy controls require a knowledge of the dependence of E on V. We have analyzed the extinction per platelet (e) as a function of the geometric scattering cross-section of equivalent spheres, V^2/3, related to the apparent mean platelet optical efficiency, k. Such an analysis using data previously reported by Holme et al., for healthy controls and a variety of platelet-associated disorders showed e/V^2/3 or k to be constant over an eight-fold variation in V. The outstanding exception was platelet suspensions from myeloproliferative disorder patients (MPD) which showed ˜25% reduction in k values. When we analyzed e/V^2/3 data for differentsized platelet subpopulations which were isolated by elutriation from healthy donors, we found that k doubled with a doubling in V from small to large platelets. It appears that the use of aggregometry devices with wide light acceptance angles yields k values for platelets which are insensitive to variations in V, but rather are sensitive to the expected variations in refractive index associated with distinct platelet internal composition and organization expected for different-sized normal subpopulations and “diseased” platelets as found in MPD. We relate these observations to photometric studies of platelet heterogeneity and of aggregation of platelets with different V and k values.

• References

• 1 Latimer P. Light scattering and absorption as methods of studying cell population parameters. Annu Rev Biophys Bioeng 1982; 11: 129-150
• 2 Frojmovie MM. Rheooptical studies of platelet structure and function. Progr Hemostas Thromb 1978; 4: 279-319
• 3 Seiber BA, Latimer P. Extinction efficiencies of large latex spheres. J Colloid Interf Sci 1967; 23: 509-512
• 4 Frojmovic MM, Panjwani R. Blood cell structure-function studies: light transmissions and attenuation coefficients of suspensions of blood cells and model particles at rest and with stirring. J Lab Clin Med 1975; 326-343
• 5 Milton JG, Frojmovic MM. Turbidometric evaluations of platelet activation: relative contributions of measured shape change, volume, and early aggregation. J Pharm Methods 1983; 9: 101-115
• 6 Holme S, Simmonds M, Ballek R, Murphy S. Comparative measurements of platelet size by Coulter Counter, microscopy of blood smears, and light transmission studies. J Lab Clin Med 1981; 97: 610-622
• 7 Wong T, Pedvis L, Frojmovic M. Platelet size affects both micro- and macro-aggregation: contributions of platelet number, volume fraction and cell surface. Thromb Haemostas 1989; 62: 733-741
• 8 Yasaka T, Boxer LA, Backner RL. Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF). J Immunol 1982; 128: 1939-1944
• 9 Yuli I, Snyderman R. Light scattering by polymorphonuclear leukocytes stimulated to aggregate under various pharmacologic conditions. Blood 1984; 64: 649-655
• 10 Rochon YP, Frojmovic MM, Mills EL. Comparative studies of microscopically-determined aggregation, degranulation, and light transmission after chemotactic activation of adult and newborn neutrophils. Blood 1990; 75: 2053-2060
• 11 Frojmovic MM, Panjwani R. Geometry of normal mammalian platelets by quantitative microscopic studies. Biophys J 1976; 16: 1071-1089
• 12 Latimer P. The influence of photometer design on optical-conformational changes. J Theor Biol 1975; 51: 1-12
• 13 Shapiro HH. Chapter 7. In: Practical Flow Cytometry Alan R Liss Inc., New York: 1985
• 14 Thompson CB, Eaton KA, Princiotta SM. et al. Size dependent platelet subpopulation relationships of volume to ultrastructure, enzymatic activity and function. Br J Haematol 1982; 50: 509-519
• 15 Frojmovic MM, Milton JG. Physical, chemical and functional changes following platelet activation in normal and “giant” platelets. Blood Cells 1983; 9: 359-382
• 16 Milton JG, Frojmovic MM. Adrenaline and adenosine diphosphate-induced platelet aggregation require shape change. J Lab Clin Med 1984; 104: 805-815
• 17 Frojmovic MM, Milton JG, Gear AL. Platelet aggregation measured in vitro by microscopic and electronic particle counting. Methods Enzymol 1989; 169: 134-149
• 18 Milton JG, Hutton RA, Tuddenham EG D, Frojmovic MM. Platelet size and shape in hereditary giant platelet syndromes on blood smear and in suspension: evidence for two types of abnormalities. J Lab Clin Med 1985; 106: 326-335
• 19 Milton JG, Yung W, Frojmovic MM. Dependence of platelet volume measurements on heterogeneity of platelet morphology. Biophys J 1981; 35: 257-261
• 20 Latimer P, Moore DM, Bryant FD J. Changes in total light scattering and absorption caused by changes in particle conformation. Theor Biol 1968; 21: 348-367
• 21 Latimer P, Born GV R, Michal F. Application of light scattering theory to the optical effects associated with the morphology of blood platelets. Arch Biochem Biophys 1977; 180: 151-159
• 22 Patscheke H, Warner P. Platelet activation detected by turbidimetric shape-change analysis. Differential influence of cytochalasin B and prostaglandin E. Thromb Res 1978; 12: 485-496
• 23 Penington DG, Streatfield K, Roxburgh AE. Megakaryocytes and the heterogeneity of circulating platelets. Br J Haematol 1976; 34: 639-653
• 24 Eche N, Sie P, Caranobe C, Nouwel C, Pris J, Boneu B. Platelets in myeloproliferative disorders: glycoprotein profile in relation to platelet function and platelet function and platelet density. Scand J Haematol 1981; 26: 123-9
• 25 Clezardin P, McGregor JL, Dechavanne M, Clemetson KJ. Platelet membrane glycoprotein abnormalities in patients with myeloproliferative disorders and secondary thrombocytosis. Br J Haematol 1985; 60: 331-344
• 26 Landolfi R, De Cristofora R, Castagnola M. et al. Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders. Blood 1988; 71: 978-982
• 27 Carty DJ, Gear AR L. Fractionation of platelets according to size: functional and biochemical characteristics. Am J Haematol 1986; 21: 1-6
• 28 Corash L, Tan H, Gralnick HR. Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume and ultrastructure. Blood 1977; 49: 71-87
• 29 Frojmovic MM, Milton JG. Human platelet size, shape and related functions in health and disease. Physiol Rev 1982; 2: 185-261
• 30 Bessman DJ, Gilmer PR, Gardner FH. Use of mean platelet volume improves detection of platelet disorders. Blood Cells 1985; 11: 127-135
• 31 Bessman DJ, Williams LJ, Gilmer Jr PR. Platelet size in health and hematologic disease. Am J Clin Pathol 1982; 78: 150-153
• 32 Holme S, Heaton A, Konchuba A. et al. Light scatter and total protein signal distribution of platelets by flow cytometry as parameters of size. J Lab Clin Med 1988; 112: 223-231
• 33 Holme S, Murphy S. Influence of platelet count and size on aggregation studies. J Lab Clin Med 1981; 97: 623-630
• 34 Frojmovic MM. Comparative studies of turbidimetrically-measured rates of platelet aggregation require adjustment of the platelet suspension according to the mean relative size and optical efficiency of the platelets used. Blood 1989; 74: 2302
• 35 Reardon DM, Hutchinson D, Preston FE, Trowbridge EA. The routine measurement of platelet volume: a comparison of aperture-impedance and flow cytometric systems. Clin Lab Haematol 1985; 7: 251-257
• 36 McGann LE, Walterson ML, Hogg LM. Light scattering and cell volumes in osmotically stressed and frozen-thawed cells. Cytometry 1988; 9: 33-38